NCT03496649View on ClinicalTrials.gov

Pubalgia and Adductor Tendinopathies Refractory to Medical Treatment

PHASE2UnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 2, 2019

Primary Completion Date

August 2, 2020

Study Completion Date

August 2, 2020

Conditions
Groin InjuryTendinopathy
Interventions
DRUG

Dysport 500 Unit Powder for Injection

Dysport administered by intramuscular injection

Trial Locations (1)

33076

RECRUITING

CHU de Bordeaux, Bordeaux

Sponsors

Collaborators (1)

Ipsen
All Listed Sponsors
collaborator

Ipsen

INDUSTRY

lead

University Hospital, Bordeaux

OTHER

NCT03496649 - Pubalgia and Adductor Tendinopathies Refractory to Medical Treatment | Biotech Hunter | Biotech Hunter